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Abstract
Background: Glucagon like peptide-1 (GLP-1) and its analogue exendin-4 (Ex-4) enhance glucose stimulated insulin
secretion (GSIS) and activate various signaling pathways in pancreatic b-cells, in particular cAMP, Ca2+ and protein kinase-B
(PKB/Akt). In many cells these signals activate intermediary metabolism. However, it is not clear whether the acute
amplification of GSIS by GLP-1 involves in part metabolic alterations and the production of metabolic coupling factors.
Methodology/Prinicipal Findings: GLP-1 or Ex-4 at high glucose caused release (,20%) of the total rat islet insulin content
over 1 h. While both GLP-1 and Ex-4 markedly potentiated GSIS in isolated rat and mouse islets, neither had an effect on b-
cell fuel and energy metabolism over a 5 min to 3 h time period. GLP-1 activated PKB without changing glucose usage and
oxidation, fatty acid oxidation, lipolysis or esterification into various lipids in rat islets. Ex-4 caused a rise in [Ca2+]i and cAMP
but did not enhance energy utilization, as neither oxygen consumption nor mitochondrial ATP levels were altered.
Conclusions/Significance: The results indicate that GLP-1 barely affects b-cell intermediary metabolism and that metabolic
signaling does not significantly contribute to GLP-1 potentiation of GSIS. The data also indicate that insulin secretion is a
minor energy consuming process in the b-cell, and that the b-cell is different from most cell types in that its metabolic
activation appears to be primarily governed by a ‘‘push’’ (fuel substrate driven) process, rather than a ‘‘pull’’ mechanism
secondary to enhanced insulin release as well as to Ca2+, cAMP and PKB signaling.
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Introduction
The mechanisms of glucose-stimulated insulin secretion (GSIS)
in the b-cell remain to be defined. In addition to the triggering
pathway involving a rise in ATP production, KATP channel
closure and a Ca2+ rise [1,2,3], fuel signaling is thought to involve
additional pathways, in particular anaplerosis/cataplerosis, pyru-
vate cycling processes, endogenous lipolysis and enhanced
glycerolipid/fatty acid (GL/FFA) cycling [4,5,6,7,8,9]. Besides
the signals induced by calorigenic nutrients and their associated
production of metabolic coupling factors [4], b-cell function is
modulated by a variety of neurohormonal agents and glucoincre-
tins [10], including glucagon like peptide-1 (GLP-1), an incretin
hormone secreted by the L-cells of the distal intestine [10,11].
GLP-1 levels in the plasma increase rapidly following a meal [12],
and this hormone has a profound glucose-lowering effect through
both central and peripheral actions [13], the latter effect being
particularly at the level of the b-cell [10]. GLP-1 stimulates insulin
gene expression [14], proinsulin biosynthesis [10], and it also
potentiates GSIS [10,14]. GLP-1 also has proliferative [15] and
antiapoptotic actions on the b-cell [10]. The biologically active
form of GLP-1 is derived from proglucagon via the action of
prohormone convertase enzymes [10,11], and circulating GLP-1 is
rapidly removed from the circulation following its degradation by
dipeptidyl peptidase-4 (DPP-4) [16].
GLP-1 exerts its cellular action by binding to its receptor, a G-
protein coupled receptor (GLP-1R), expressed in b-cells, nervous
system, heart and kidney [10,11]. The activation of the GLP-1R
leads to the induction of many signal transduction systems,
including cAMP, Ca2+, PI3-Kinase and EGF receptor signaling
[10,11,17,18]. These multiple actions of GLP-1 are also observed
upon exposure of b cells to Exendin-4 (Ex-4), a peptide that is an
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incretin mimetic and which lowers levels of blood glucose as a
consequence of its ability to activate the GLP-1R [10]. GLP-1
induces insulin secretion during short-term exposure to the
hormone, or after chronic exposure to the hormone [10,19].
Even though the precise mechanisms of GLP-1 action are not fully
understood, it is established that the stimulation of GSIS by GLP-1
involves activation of membrane-bound adenylyl cyclase and
cAMP production, leading to protein kinase-A (PKA) and Epac
[20] activation, and an increase in intracellular Ca2+ [10,11,21]. A
rise in cytoplasmic and mitochondrial Ca2+ has been linked to the
activation of mitochondrial dehydrogenases, in particular pyruvate
dehydrogenase [22], a-ketoglutarate dehydrogenase and isocitrate
dehydrogenase [3,22,23]. Additionally, islet tissue and the b-cell
contain some glycogen [24,25] that might be mobilized following a
rise in cellular Ca2+ or cAMP [26], thus releasing glucose-1P that
may enter the glycolytic pathway following its conversion to
glucose-6-P. It is therefore attractive to hypothesize that GLP-1
may indirectly activate b-cell energy metabolism, thereby raising
levels of cellular ATP, and possibly influencing other metabolic
coupling factors, via its effect on cellular levels of Ca2+ and cAMP.
Thus, it is generally believed that the cAMP and Ca2+ pathways
cannot fully account for the complete magnitude of GLP-1
mediated GSIS enhancement [10,11,19].
Besides Ca2+ signaling, the binding of GLP-1 to its receptor also
results in the activation of protein kinase-B (PKB/Akt) [27,28,29]
and PKB activation in other cell types has been linked to various
metabolic effects, including glucose transport in muscle [30]
glycogen synthesis [31] and lipolysis [32]. It can also be
hypothesized that an increase in cellular ATP content might
inactivate AMP-activated protein kinase (AMPK) [33], as elevated
glucose does [34], which may lead to reduced phosphorylation of
hormone sensitive lipase and adipose triglyceride lipase [35], with
subsequent enhanced lipolysis [36] and activation of the lipid
amplification arm of glucose signaling for insulin secretion [36].
Thus, our previous work has established a role for lipolysis in GSIS
[37,38]. In addition, it was previously shown that orlistat, a pan-
inhibitor of lipases, suppresses the incretin action of GLP-1 [39],
and that GLP-1 enhances lipolysis in HIT (b) cells [40].
In the present study we examined whether the acute stimulation
of GSIS by GLP-1 or Ex-4 involves the modulation of glucose,
fatty acid and energy metabolism in the b-cells, as studied using
isolated islets of both rats and mice. The study was designed to
respond to four questions of general interest for b-cell neuropep-
tide and fuel signaling. 1) Does GLP-1 amplify GSIS in part by
metabolic signaling? 2) Does the activation of major cellular
signaling processes (Ca2+, cAMP, PKB etc) in response to a
physiological peptide agonist changes b-cell metabolism? 3) Does
enhanced insulin secretion contribute significantly to total energy
consuming processes in the b-cell? 4) Is the b-cell similar or
different from most tissues in term of metabolic activation,
specifically whether it is primarily governed by a ‘‘push’’ (fuel
substrate driven) process, rather than a ‘‘pull’’ mechanism
secondary to enhanced activation of its major cellular function.
Materials and Methods
Animals and diets
Ethics Statement. All procedures were performed in
accordance with the Institutional Committee for the Protection
of Animals at the Centre Hospitalier de l’Universite´ de Montre´al
or Institutional Guidelines for Animal Care (IACUC) at the
Marine Biological Laboratory, in compliance with United States
Public Health Service regulations.
Wistar rats (200–250 g; Charles River) and male Swiss-Webster
mice or male CD-1 rats were housed under controlled temper-
ature (21uC) and light conditions (12-h light/dark cycle) with free
access to water and standard chow diet.
Isolation and culture of islets and islet cells
Pancreatic islets were isolated by collagenase digestion of the
pancreas according to Gotoh et al [41]. After digestion and
washing and separation by histopaque gradient centrifugation,
islets were hand-picked and cultured overnight in a humidified
incubator with 5% CO2. For measurements of insulin secretion,
the cell culture medium was RPMI-1640 containing 11 mM
glucose and supplemented with 10% foetal calf serum, 10 mM
HEPES (pH 7.4), 1 mM sodium pyruvate, 100 U/ml penicillin
and 100 mg/ml streptomycin (RPMI complete medium). For
measurements of oxygen consumption, isolated rat or mouse islets
were cultured overnight in RPMI-1640 complete medium
containing 5 mM glucose. For single cell studies of mitochondrial
ATP levels, the islets were dispersed by incubation in Ca2+/Mg2+
free phosphate buffered saline, 3 mM EGTA and 0.002% trypsin
as previously described [42]. Islet cells obtained by dispersion of
islets were plated on poly-D-lysine coated coverslips (MatTek,
Ashland, MA) in 35 mm Petri dishes. After 24 h, single islet cells
were transduced with Ad-MitoLuc-RFP at 50 MOI (multiplicity of
infection) for 12 h, after which viral media were replaced with
appropriate growth media. Transduction efficiency in single islet
cells, determined from RFP fluorescence, reached more then 90%
under these conditions.
Measurement of insulin secretion and insulin content
After overnight culture, rat islets were distributed in 12-well
plates (10 islets/well) and incubated for 2 h in 1 ml RPMI
complete medium containing 2.8 mM glucose. The islets were
then washed and pre-incubated for 45 min at 37uC in KRBH/
0.07% defatted BSA and 2.8 mM glucose, followed by incubation
for 1 h in 1 ml KRBH/0.5% defatted BSA and 2.8, 8.3 or
16.7 mM glucose plus or minus 20 nM GLP-1-(7–36)-amide
(Bachem Americas, Torrance, CA, USA) or 20 nM Ex-4 (Bachem
Americas, Torrance, CA, USA), in the presence or absence of
0.3 mM palmitate. For whole mouse islets, or populations of single
mouse islet cells (plated on the wells of 48-well plates), insulin
secretion was measured at 4, 7.5 and 16.7 mM glucose in the
presence or absence of 10 nM Ex-4. At the end of a 30 min static
incubation, media were kept for insulin measurement by
radioimmunoassay (Linco research, St. Charles, MO, USA). Islet
total insulin content was measured following acid-ethanol (0.2 mM
HCl in 75% ethanol) extraction.
Islet fatty acid oxidation and esterification
Fatty acid (FA) oxidation and esterification were determined in
batches of 50 islets cultured as described above. After 2 h
incubation in 2.8 mM glucose-RPMI complete medium, islets
were washed in KRBH/0.25% BSA and pre-incubated for 45 min
at 37uC in KRBH/0.25% defatted BSA and 2.8 mM glucose after
which they were incubated for 2 h (FA oxidation) or 4 h (FA
esterification) in 1 ml KRBH/0.25% defatted BSA containing 2.8,
8.3 or 16.7 mM glucose in the presence or absence of 20 nM
GLP-1, 0.1 mM (oxidation) or 0.2 mM (esterification) palmitate,
1 mCi/ml [9,10(n)-3H] palmitate (51 Ci/mmol, GE Healthcare,
Baie d’Urfe´, QC, Canada), and 1 mM carnitine. At the end of the
incubation, the media were collected for the determination of islet
FA oxidation and total lipids were extracted from islets for the
measurement of islet FA esterification [38].
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Glucose oxidation and utilization
Groups of 20 islets cultured and pre-incubated as described
above for the insulin secretion assay, were incubated in a 0.6 ml
Eppendorf tube without capping, in a final volume of 70 ml
KRBH/0.25% defatted BSA containing 2.8 to 16.7 mM glucose
with D-[U-14C]-glucose for oxidation measurements (250 mCi/
mmol, PerkinElmer, Canada) and D-[5-3H]-glucose for utilization
measurements (16 Ci/mmol, GE Healthcare, Canada) with or
without 20 nM GLP-1 [43]. For oxidation incubations, this
incubation tube was placed upright in an airtight-sealed 20 ml
scintillation vial, which also contained an empty 1.5 ml Eppendorf
tube without capping. The reaction was stopped after 90 min
incubation at 37uC with constant agitation by the addition of 50 ml
of a mix consisting of metabolic poisons (400 mM citric acid,
10 mM rotenone, 10 mM antimycin and 3.5 mg KCN, pH 4.9).
To the empty 1.5 ml tube in the scintillation vial, 250 ml of 5% (w/
v) KOH was added to trap released 14CO2. Incubations were
continued for 60 min at room temperature and glucose oxidation
was determined by measuring the KOH-trapped 14CO2. For
utilization measurements, the scintillation vial also contained
500 ml of 1 mM HCl at the bottom. After stopping the incubations
as above, the tightly sealed vials were left at room temperature for
40 h and glucose utilization was determined by measuring the
amount of 3H2O equilibrated into the 0.5 ml HCl in the vial.
Lipolysis
Batches of 60 islets, cultured as described above, were washed in
KRBH/0.07% BSA and 2.8 mM glucose and were transferred
into 0.2 mL of KRBH/0.07% BSA medium in a 48 well plate
with 2.8, 8.3 or 16.7 mM glucose and 20 nM GLP-1 or 20 nM
Ex-4. The plate was incubated for 3 h at 37uC in a humidified
atmosphere containing 5% CO2, after which the media were
collected for glycerol determination by an enzymatic assay [37].
Islet protein content was measured, as previously described [37].
Measurement of [Ca2+]i and cAMP content
Mouse islets were dispersed by mild digestion with trypsin-
EDTA and the single islet cells were plated on glass cover-slips for
[Ca2+]i measurement, or in 96-well cell culture plates for cAMP
determination. After overnight culture, the islet cells were infected
with Ad-MtLuc-RFP (m.o.i. equal to 50). Measurements of [Ca2+]i
were performed after 48 h, using fura-2 loaded b-cells, imaged at
100X magnification using a dual excitation light source and a
ratiometric imaging system (IonOptix Corp.) equipped with filter
sets that minimize crossover between fura-2 and RFP [44]. The
cAMP content was determined by immunoassay using a Direct
Biotrak EIA kit (Amersham) as described earlier [45].
Oxygen Consumption
Oxygen consumption in single rat or mouse islets was measured
at 37uC in the presence or absence of 10 nM Ex-4 or 10 mM
forskolin by the self-referencing method based on an electrochem-
ical oxygen sensor (BioCurrents Center, MBL, Woods Hole, MA)
moving between a ‘‘near’’ and ‘‘far’’ position at the islet. The
magnitude of the amperometric current used for the reduction of
oxygen is proportional to the oxygen concentration at that
particular point [46]. When islet respires, oxygen concentration
is lower at near position. Thus, the current used for reduction of
oxygen on the sensor will be greater at the far position, and the
measured difference in the electric current between far and near
position (Difference Current, DC) is greater than zero. When an
islet further increases oxygen consumption (in response to a rise in
glucose concentration), oxygen concentration at near position
decreases even more and causes further increase in the DC.
Oxygen consumption was measured in islets incubated in KRBH
containing 4, 7.5, and 16.6 mM glucose.
Mitochondrial ATP
Changes of mitochondrial ATP levels (ATPm) were measured in
a population of approximately 250,000 single rat or mouse islet cells
infected with Ad-MitoLuc-RFP. This virus was generated using the
mt-Luc coding sequence in plasmid VR102. mt-Luc is a fusion
protein in which the 26 amino acid N-terminal signal peptide of
cytochrome C oxidase subunit VIII (COX8) is fused to codon-
optimized firefly luciferase [47]. Ad-MitoLuc-RFP infected islet cells
were incubated with KRBH buffer (for 72 h) containing, either 4,
7.5 or 16.6 mM glucose without or with 10 nM Ex-4. Single islet
cells, grown and infected on the PDL-coated glass coverslips inside a
35 mm dish (MatTek, Ashland, MA) were placed directly onto the
surface of the photocathode optical window of a Hamamatsu R464
photomultiplier tube housed in a 37uC heated box. Luciferin was
then added to the KRBH at a final concentration of 100 mM in
order to allow the measurement of photoemissions resulting from
luciferase-catalyzed oxidation of luciferin [48].
PKB/Akt phosphorylation
A group of 200 islets cultured and pre-incubated as described
for insulin secretion experiments, was incubated for 30 min in
1 ml KRBH/0.5% defatted BSA containing 2.8 or 8.3 mM
glucose in the presence or absence of 20 nM GLP-1. After 30 min,
islets were lysed in 0.1 ml of 50 mM HEPES (pH 7.5), 2 mM
sodium orthovanadate, 4 mM EDTA, 100 mM sodium fluoride,
10 mM sodium pyrophosphate, 1 mM PMSF, 1% (v/v) NP40 and
protease inhibitors. Total cellular proteins were obtained after
sonicating the islets for 10 s and centrifugation at 15,0006g at 4uC
for 12 min. The supernatant was collected and the protein content
assayed (Pierce). Proteins were resolved by 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and elec-
trotransferred to nitrocellulose membranes (BioRad, Hercules,
CA, USA). After overnight blocking with 5% non-fat milk, the
membranes were probed with antibodies for pSer473-PKB and
total PKB (Cell Signaling Technology, MA, USA) and the proteins
were visualized by enhanced chemiluminescence (Pierce).
Statistical analysis
Data are expressed as means6SE. Significance was calculated
for multiple comparisons by using one-way analysis of variance
(ANOVA) with Bonferroni post-hoc testing. A P-value of,0.05
was considered significant.
Results
Glucose stimulated insulin secretion from isolated rat islets in a
dose-dependent manner, and this effect was enhanced by 0.3 mM
palmitate at an intermediate concentration (8.3 mM) of glucose
(Fig. 1A). Both GLP-1 and Ex-4 markedly potentiated GSIS at 8.3
and 16.7 mM glucose, and palmitate did not further elevate
insulin secretion. At 16.7 mM glucose, GLP-1 and Ex-4 stimulated
insulin secretion 3–4 fold more than glucose alone. In the presence
of GLP-1 or Ex-4 the amount of insulin released during the
45 min time period corresponded to approximately 20% of the
total islet content of insulin. In mouse islets, Ex-4 enhanced GSIS
at 7.5 and 16.7 mM glucose, but not at 4 mM glucose (Fig. 1B).
Overall, Fig. 1 shows that the islets that were used in the current
study were highly responsive to glucose, GLP-1 and Ex-4 and
therefore suitable to be used to respond to the addressed questions.
Inasmuch as both GLP-1 and Ex-4 are agonists of GLP-1 receptor
GLP-1 & b-Cell Fuel Metabolism
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on the b-cells, with near equal potency, most studies to date have
not found any significant differences between these two agonists in
in vitro experiments. In the present study, although most
experiments were performed with both GLP-1 and Ex-4, because
of the similar nature of the data, only either of these is illustrated.
PKB has multiple metabolic effects in various cell types [49] and
GLP-1 acutely activates PKB in INS cells [27] and human islets
[29]. So far it has not been shown that GLP-1 activates PKB in
normal rodent b-cells. We examined the effect of GLP-1 (20 nM)
on PKB phosphorylation in rat islets after a 30 min exposure to
the hormone, and observed that GLP-1 significantly increased Ser-
473 phosphorylation of PKB in normal islet cells (Fig. 2).
It was therefore of interest to determine whether changes in islet
intermediate metabolism might be explained by influences of
GLP-1 on PKB phosphorylation/activation [50,51], in addition to
its previously demonstrated stimulatory effects on islet cAMP and
Ca2+ signaling shown in many studies employing both normal
(human, rat, mouse) and tumoral b-cell (for reviews see
[3,10,19,20,21]). Tsuboi and co-workers [52] reported that
GLP-1 receptor activation increased [Ca2+]i, which caused an
elevation of mitochondrial ATP in MIN6 insulin-secreting cells. In
order to ascertain that Ex-4 increases [Ca2+]i and cAMP in normal
mouse b-cells under our experimental conditions where mito-
chondrial ATP and O2 consumption were measured, single cell
measurements of [Ca2+]i were performed using b-cells loaded with
fura-2, infected with Ad-MtLuc-RFP, and equilibrated in KRB
containing 5.6 mM glucose. Under these conditions, Ex-4 (10 nM)
stimulated an increase of [Ca2+]i in these cells (Fig. 3A).
Importantly, MtLuc expression had no effect on the percentage
of cells exhibiting a .100 nM increase of [Ca2+]i (Fig. 3B). Thus,
viral infection did not disrupt the stimulatory action of Ex-4 on
intracellular Ca2+ signaling. Since Ex-4 is known to stimulate
insulin secretion in a glucose-dependent manner, we examined
whether glucose concentration influences Ex-4 stimulated intra-
cellular Ca2+ signaling. This was in fact the case since the action of
Ex-4 to increase [Ca2+]i was more prominent under conditions in
which mouse b-cells were equilibrated in KRB containing 7.5 mM
glucose as compared to 5.6 mM glucose (Fig. 3B).
Since it is known that the increase of [Ca2+]i in response to Ex-4
is secondary to b-cell cAMP production [44], it was of interest to
Figure 1. Acute effects of GLP-1 and Ex-4 on GSIS in rat (A) and mouse (B) islets. Pancreatic islets were isolated and cultured overnight
prior to use as described in Methods. Islets were incubated for 1 h (A) or 30 min (B) as described in Methods for examining insulin secretion at
indicated concentrations of glucose and GLP-1 (20 nM) or Ex-4 (20 nM) in A, or 10 nM Ex-4 in B, in the absence or presence of 0.3 mM palmitate.
Insulin released into the media and the total islet insulin content were measured. Results shown are mean6SE from 3 independent experiments with
quadruplicates (n = 12). For A, *p,0.05, **p,0.01, ***p,0.001 when compared with corresponding 2.8 mM glucose group. #p,0.05, ##p,0.01,
###p,0.001 when compared with corresponding groups without GLP-1 or Ex-4 treatment. For B, {p,0.01 when compared to corresponding
minus Ex-4 group. Insulin secretion in mouse islets at basal glucose levels (4 mM) was 1.5660.3 ng insulin/10 islets/30 min.
doi:10.1371/journal.pone.0006221.g001
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determine if viral infection altered the ability of Ex-4 to increase
levels of cAMP in primary mouse islet cells. We found that Ex-4
stimulated cAMP production in a dose-dependent manner, in islet
cells infected with Ad-MtLuc-RFP (Fig. 3C), without any
significant difference from cells not infected with Ad-MtLuc-RFP
(Fig. 3C). Thus, viral infection as described here for Ad-MtLuc-
RFP, did not disrupt intracellular Ca2+ signaling and cAMP
production in mouse b-cells.
We have previously shown [53,54] that GSIS in rat islets and
INS cells is accompanied by reduced b-oxidation and increased
partitioning of fatty acids into glycerolipids, an event that is
thought to be coupled to b-cell activation of insulin release [5].
Therefore, we examined whether the acute stimulatory effect of
GLP-1 on GSIS in islets might result from altered lipid
metabolism. There was no significant effect of GLP-1 on palmitate
oxidation or its incorporation into different classes of glycerolipids
or cholesterol esters or phospholipids (Fig. 4) at the various tested
glucose concentrations.
We next assessed whether the acute stimulatory effect of GLP-1
on GSIS is associated with changes in islet glucose metabolism.
However, rat islet glucose utilization (Fig. 5A) or oxidation (Fig. 5B)
was not significantly affected by GLP-1 at all tested glucose
concentrations, except for a small increase in utilization at
16.7 mM glucose (Fig. 5A).
Enhanced lipolysis and GL/FFA cycling are thought to play a
role in the amplification (KATP-independent) arm of fuel induced
insulin secretion [5,35], and previous work in the HIT cell line
showed that GLP-1 enhances glycerol release in this tumoral (b)
cell [40]. However, GLP-1 did not enhance lipolysis in rat islets at
low, intermediate and high glucose (Fig. 5C).
We also examined the effect of Ex-4 and GLP-1 on oxygen
consumption at different glucose concentrations in rat and mouse
islets since this parameter reflects overall fuel utilization and
metabolic activation of a given tissue. Even though oxygen
consumption increased with glucose concentration, there was no
significant change with Ex-4 (Fig. 6A & B) or with GLP-1 (data not
shown), in accordance with the results from glucose oxidation
experiments. Also, the adenylate cyclase activator forskolin
(10 mM) did not affect oxygen consumption in mouse islets (data
not shown).
Enhanced mitochondrial metabolism and ATP production
plays a central role in b-cell fuel signalling [55] and GLP-1 was
shown to enhance mitochondrial ATP production in the tumoral
b-cell line MIN6 [52]. We further measured mitochondrial ATP
levels in isolated rat and mouse islet cells engineered to express
mitochondrial-targeted luciferase, after incubation for 5 to 30 min,
with different glucose concentrations and Ex-4. Glucose caused a
marked and dose dependent increase in mitochondrial ATP,
within 5 min of incubation, in both rat and mouse islets cells, but
Ex-4 did not significantly change mitochondrial ATP at all tested
glucose concentrations (Fig. 7A & B). Identical results were
obtained using 20 nM GLP-1 (data not shown). We verified that
the mitochondrial-luciferase-engineered islet cells respond nor-
mally to the respiratory substrates and inhibitors, by examining the
effect of methylsuccinate (10 mM), a membrane permeable form
of succinate and FCCP (10 mM), an uncoupler of oxidative
phosphorylation. As expected, during a 15 min incubation,
methylsuccinate enhanced ATP production above the basal
(4 mM glucose) level, whereas, FCCP reduced ATP levels (data
not shown).
Discussion
Fuel stimulated insulin secretion in the b-cells involves the
production of metabolic coupling factors and an elevation in
intracellular Ca2+ [1]. GLP-1 and Ex-4 enhance GSIS in the b-cells,
cause a rise in cytosolic Ca2+, elevate cAMP and activate the PKA
and PKB signaling pathways [3,10,19,20,21]. Because activation of
Ca2+, cAMP and PKB signaling is known to modulate intermediary
and energy metabolism in several cell types, we hypothesized that
GLP-1 signaling to stimulate insulin secretion is in part linked to
changes in b-cell metabolism and the production of metabolic
coupling factors. The data in fact show that GLP-1 or Ex-4 barely
affect b-cell metabolism at large, and therefore that GLP-1 induced
insulin secretion may not involve metabolic signaling related to
glucose, lipid and energy metabolism.
We [1,5] and others [56] provided evidence that enhanced
lipolysis in b-cells plays a role in GSIS. However, lipolysis does not
appear to be involved in the acute amplification of GSIS by GLP-1
in normal islet tissue. Thus, in accordance with a previous study
using isolated mouse islets [57], we observed that GLP-1 or Ex-4
do not affect rat islet lipolysis. Furthermore, islets from hormone
sensitive lipase-KO mice exhibited GLP-1 stimulation of GSIS
similar to that of control mouse islets [37]. The previously reported
increase in lipolysis by acute treatment with GLP-1 in HIT (b) cells
[40] is probably due to the inherent differences in established
tumoral cell lines from normal islet b-cells.
Lipid amplification pathways of GSIS in the b-cell involve
reduced fatty acid b-oxidation and concomitant increased
esterification of fatty acids into glycerolipids [53,54]. We have
suggested that enhanced GL/FFA cycling is instrumental in the
amplification of GSIS via the generation of lipid signalling
Figure 2. PKB phosphorylation in response to GLP-1 in rat
islets. Islets were incubated for 30 min at 2.8 or 8.3 mM glucose in the
presence or absence of 20 nM GLP-1. Activation of PKB by GLP-1 was
assessed with antibodies specific for Ser473phospho-PKB and PKB,
respectively. (A) Representative immunoblot of phospho- and total PKB
in rat islets. (B) Quantitative measurement of PKB phosphorylation after
30 min treatment with GLP-1. Results are means6SE of 4 separate
experiments. #p,0.05, when compared to the corresponding ‘minus
GLP-1’ group.
doi:10.1371/journal.pone.0006221.g002
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molecules that act as metabolic coupling factors for insulin
secretion [5,35]. However, no effect of GLP-1 was noticed on
either palmitate b-oxidation or its incorporation into glycerolipids,
cholesterol esters or phospholipids. Thus, GLP-1 mediated
enhancement of GSIS does not appear to be dependent on either
lipolysis or alteration in GL/FFA cycling.
GLP-1 activates PKB in INS (b)-cells [27,28], human [29] and
rat islets (present study). PKB activation can lead to various
metabolic effects in different cell types, including glucose transport
[30] and glycogen synthesis [31] in muscle, and lipolysis in
adipocytes [32]. In addition PKB activation inhibits AMPK [33],
and activation of AMPK by AICAR or expression of a
constitutively active AMPK mutant in b-cells curtail GSIS
[34,58]. However, despite GLP-1 activation of islet PKB, none
of the studied parameters of b-cell metabolism were changed,
suggesting that b-cell PKB activation is not linked to acute changes
in b-cell metabolism.
Measurements of mitochondrial ATP, which rapidly increase
within 5 min and respiration as oxygen consumption in rat and
mouse islets revealed no change with Ex-4, in accordance with
glucose oxidation measurements showing no effect of GLP-1. This
indicates that GLP-1 does not amplify GSIS via changes in b-cell
energy metabolism. Earlier work on the acute actions of GLP-1 on
b-cell energy metabolism using the tumoral b-cell line MIN-6
documented that high concentrations (100 nM) of GLP-1 rapidly
increased levels of ATP in both the cytosol and the mitochondrial
matrix [52]. In contrast, we now report that activation of the GLP-
1 receptor by 10 nM Ex-4 failed to alter levels of ATP in the
mitochondrial matrix of both rat and mouse islet cells over a
period of 5–30 min at different glucose concentrations. Even
though in the present study and in [52], early changes in the
mitochondrial ATP were measured (within few minutes of
incubations), the different results obtained in [52] could be
attributable to the use of excessively high GLP-1 concentration
and also the tumoral cell line, MIN6. It is also possible that the
tumoral b-cells appear to differ from normal b-cells as far as GLP-
1 action on b-cell metabolism is concerned, both in terms of
lipolysis and energy metabolism. It is possible that the interaction
of the endoplasmic reticulum with the mitochondria, as described
by Tsuboi and co-workers [52], occurs in MIN6 cells but not in
normal rodent b2cells. Thus, Ca2+ released from the endoplasmic
reticulum might not be a strong stimulus for mitochondrial ATP
production in authentic b-cells.
Collectively the present results indicate that alterations of
glucose, lipid and energy metabolism as well as ATP production
are not involved in the mechanisms whereby GLP-1 augments
GSIS. Perhaps of greater importance is the established ability of
GLP-1 to stimulate cAMP production and to activate both PKA
and Epac [19,20]. These two cAMP-binding proteins regulate b-
cell functions that are also under the control of glucose
metabolism. Such functions include KATP channel activity,
cytosolic Ca2+ handling, and insulin granule exocytosis. The
present results also show that the higher glucose concentration-
dependency of Ex-4 to stimulate insulin secretion is reflected in a
similar high glucose concentration dependence for Ex-4-mediated
[Ca2+]i increase in mouse b-cells. Ex-4-stimulated cAMP produc-
Figure 3. Exendin-4 increases [Ca2+]i and cAMP content in mouse b-cells. A, A single fura-2 loaded and Ad-MtLuc-RFP-infected mouse b-cell
was imaged to determine the [Ca2+]I, at 5.6 mM glucose in KRBH. After establishment of a stable baseline [Ca
2+]i, 10 nM Ex-4 was applied for 25 sec
(indicated by horizontal bars). Note that a repeatable increase of [Ca2+]i was measured. B, Population study conducted at the single cell level in which
the action of Ex-4 to increase [Ca2+]i was evaluated in b-cells not infected (open bars) or infected with Ad-MtLuc-RFP (filled bars). For these
experiments, the KRB contained 5.6 or 7.5 mM glucose, as indicated. A response to Ex-4 was defined as a .100 nM increase of [Ca2+]i occurring in a
single b-cell. C, Ex-4 caused a dose-dependent increase in cAMP content in mouse islet cells in KRB containing 7.5 mM glucose without or with Ad-
MtLuc-RFP infection.
doi:10.1371/journal.pone.0006221.g003
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tion, which precedes [Ca2+]i increase in islet cells [21], is not
influenced by Ad-MtLuc-RFP viral infection indicating that the
viral infection did not adversely affect the results of this study.
Thus, the insulin secretagogue action of GLP-1 likely arises as a
consequence of its ability to facilitate the action of glucose-derived
metabolic coupling factors, rather than by directly stimulating
metabolic signaling per se.
Another aspect of the present study is that it provides new
information about b-cell activation of energy metabolism of this
fuel sensing cells with respect to other tissues. In many cell types
like muscle tissue, the activation of their primary biological
function and energy demanding process drives mitochondrial
metabolism via changes in redox, phosphorylation potential or
Ca2+. In the present study, it came as a surprise that in spite of a
very significant enhancement in GSIS by GLP-1 and Ex-4 at high
glucose in both rat and mouse islets, amounting to approximately
20% of the total insulin content in 1 h (in the case of rat islets), no
concomitant rise in fuel utilization, O2 consumption or ATP
production was noticed. These results indicate that the energy
consuming processes activated by GLP-1 and likely other
glucoincretins, such as ion ATP-ases, the release of insulin from
the ready-releasable pool of secretory granules, the ATP-
dependent [59] refilling of this pool and recycling of excess
plasma membrane via endocytosis following exocytosis, consume
very little energy relatively to overall cell metabolism.
Recent studies in fact revealed that much of the energy needed
for the secretory granule membrane fusion comes from the
conformational changes of the proteins involved in this process.
Thus, the energy needed for the fusion of membranes overcoming
the repulsive forces, arises from the formation and folding of v-
and t-SNARES [60]. In vitro experiments using artificial lipid
bilayers demonstrated that the formation of a single SNARE
complex (the v- and t-SNARE complex) provides sufficient energy
for the fusion of the outer leaflets of the bilayers [61]. Release and
re-cycling of v- and t-SNARES in high-energy form is accom-
plished by the involvement of the SNAP and NSF ATPase, with
the hydrolysis of ATP, which is the only step where metabolic
energy is invested [60]. Other proteins including Munc18–1 are
Figure 4. Palmitate b-oxidation and esterification into different lipids in rat islets in the absence or presence of GLP-1. Islets were
processed as described for insulin secretion (see [Fig. 1]) and after the pre-incubation step they were incubated for 2 h (FA oxidation) or 4 h (FA
esterification) in 1 ml KRBH/0.25% defatted BSA containing medium with 1 mM carnitine and 1 mCi/ml [9,10(n)-3H] palmitate (51 Ci/mmol), at 2.8, 8.3
or 16.7 mM glucose in the presence or absence of 20 nM GLP-1. Cold palmitate (pal) was present at 0.1 mM for oxidation and 0.2 mM for
esterification experiments. A, Palmitate oxidation; B—H, palmitate incorporation into diacylglycerol, DAG (B), triacylglycerol, TG (C), monoacylglycerol,
MAG (D), non-esterified fatty acids, NEFA (E), cholesterol esters, CE (F), phospholipids, PL (G) and total glycerolipids, GL (H). Means6SE of 6–8 separate
incubations in 3 independent experiments.
doi:10.1371/journal.pone.0006221.g004
GLP-1 & b-Cell Fuel Metabolism
PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6221
also known to provide additional conformational energy to
facilitate the fusion of SNARE complexes [60]. Thus, it is likely
that the acute augmentation of GSIS at high glucose by GLP-1 is
not dependent on elevated substrate oxidation and ATP
production but may utilize the Ca2+-mediated and SNAREpin/
Munc protein conformational energy dependent fusion of the
docked secretory granules with plasma membrane to release their
insulin content. Therefore, it seems that the insulin secretion
process per se does not consume much of the b-cell metabolic
energy even upon marked insulin release.
Finally, the data indicate that the b-cell is different than most
cell types in terms of energy metabolism where activation of Ca2+,
cAMP, PKB etc signaling promoted by a stimulus drives
simultaneously a biological process (for example contraction),
and cellular metabolism/ATP production to support it. Thus, b-
cell metabolic activation appears to be primarily driven by
substrate (fuel) availability, a ‘‘push’’ process [1,62] rather than a
‘‘pull’’ mechanism secondary to enhanced insulin release.
However the data do not discount the possibility that a marked
rise in Ca2+ influx promoted by a potent secretagogue like glucose
drives mitochondrial metabolism [63]. The present study also
emphasizes the major differences that exist between normal and
tumoral b-cell in term of metabolic activation.
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Figure 5. Glucose metabolism and lipolysis in rat islets in the
absence or presence of GLP-1. Islets were processed as described
for insulin secretion (see [Fig. 1]) and after the pre-incubation step they
were incubated in 70 ml KRBH/0.25% defatted BSA medium containing
2.8, 8.3 or 16.7 mM glucose plus or minus 20 nM GLP-1 in presence of
D-[U-14C]-glucose (for oxidation) (A) and D-[5-3H]-glucose (for utiliza-
tion) (B). Incubations were stopped after 90 min as described in
Methods. Glucose oxidation was measured as 14CO2 released, and
glucose utilization was determined by measuring the amount of
released 3H2O. Results are means6SE of 15 determinations in 3 separate
experiments. *p,0.05, **p,0.01, ***p,0.001 when compared to the
corresponding 2.8 mM glucose group;#p,0.05 when compared to the
corresponding ‘minus GLP-1’ group. For lipolysis determinations (C)
overnight-cultured rat islets were washed in KRBH/0.07% BSA medium
with 2.8 mM glucose and were transferred into 0.2 mL KRBH/0.07% BSA
medium with 2.8, 8.3 or 16.7 mM glucose with or without 20 nM GLP-1.
After incubation for 3 h at 37uC, glycerol released into the media and
the islet protein content were determined. Means6SE from 4
independent experiments with pentaplicates.
doi:10.1371/journal.pone.0006221.g005
Figure 6. Oxygen consumption of rodent islets in the absence
or presence of Ex-4. Single rat (A) and mouse (B) islets were adhered
on glass coverslips inside a 35 mm dish using CellTak adhesive. After
30 min equilibration at 4 mM glucose, oxygen consumption was
measured in response to 4, 7.5 and 16.6 mM glucose with and without
10 nM Ex-4 (10 nM). Data are means6SE of 3 experiments.
doi:10.1371/journal.pone.0006221.g006
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